Zota Health Care financials

·UnclassifiedChart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹199cr+54.6% on Q2 FY26
Net profit
−₹26.0cr−₹16.2 cr in Q2 FY26
EBITDA margin
1.5%−3.4 pts on Q2 FY26
EPS
−₹7.39−₹5.26 in Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue199129+54.6%
EBITDA3.16.3−51.6%
EBITDA margin1.5%4.9%−3.4 pts
Profit before tax−27.1−14.4—
Net profit−26.0−16.2—
EPS−₹7.39−₹5.26—

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹199 crNet profit₹−26.0 crNet margin−13.0%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
4,584————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
8.67.82.10.70.1
1.92.73.50.0—
28.728.75.614.78.9
4,606————
679539293180140
—+83.9%+62.3%+29.0%—
−0.318.5−5.77.67.3
−0.0%3.4%−2.0%4.2%5.2%
−106−63.9−48.9−12.5−4.6
−114−74.1−56.7−14.3−5.8
−16.8%−13.8%−19.4%−8.0%−4.1%
−₹32.57−₹21.35−₹16.28−₹4.14−₹1.67
—−31.1%−293.1%−148.5%—
—−84.4−50.0−6.0−2.0
—0.00.00.0−12.5
−84.4−84.4−50.0−6.0−14.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZOTA₹1,323.60

Zota Health Care LImited

· Unclassified
₹ CrorePeersMARINEBETATHEJOMcap ₹4,584 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————4,584.0
- Cash, Equiv & ST Investments0.10.72.17.88.6
+ Minority Interest—0.03.52.71.9
+ Total Debt8.914.75.628.728.7
Enterprise Value————4,606.0
Revenue140.0180.5293.0538.7679.1
Growth %, YoY—+29.0+62.3+83.9—
EBITDA7.37.6-5.718.5-0.3
Margin %5.244.19-1.963.44-0.04
EBIT-4.6-12.5-48.9-63.9-106.0
Net Income-5.8-14.3-56.7-74.1-114.0
Margin %-4.12-7.95-19.37-13.75-16.79
EPS, Adj (current shares)-1.67-4.14-16.28-21.35-32.57
Growth %, YoY—-148.5-293.1-31.1—
Cash from Operations-2.0-6.0-50.0-84.4—
Capital Expenditures-12.5-0.0-0.0-0.0—
Free Cash Flow-14.5-6.0-50.0-84.4-84.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Zota Health Care financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Zota Health Care (NSE: ZOTA) had a market capitalisation of ₹4,602 crore at the 30 October 2026 close (₹1,328.80 a share) and a price-to-book ratio of 7.36. In FY26 its consolidated net loss was ₹73.9 crore on revenue of ₹539 crore; in Q2 FY27 (July–September 2026) it was a loss of ₹25.6 crore. Its debt-to-equity ratio was 0.05 on 30 September 2026. Promoters held 49.38% of the shares on 30 September 2026.

Share price used
₹1,328.80 · 30 October 2026 close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

Zota Health Care at a glance · consolidated

Market cap
₹4,602 Crat ₹1,328.80 · 30 Oct close
PE ratio
n/aloss over the last 4 quarters
Price to book (PB)
7.36book value ₹180.64 a share
ROE (FY26)
−16.1%+19.8 pts vs FY25ROCE −10.4%
Debt to equity
0.05net cash ₹45.5 Cr
Promoter holding
49.38%unchanged vs 30 Jun 202630 September 2026
Net worth
₹626 Cr+98.1% vs 30 Sep 202530 September 2026
Free cash flow (FY26)
−₹84.4 Cr
EPS (FY26)
−₹22.46

Questions

What is the Zota Health Care PE ratio today?

Zota Health Care's PE ratio is not meaningful at the 30 October 2026 close: its consolidated net profit over the last four quarters (Q3 FY26 to Q2 FY27) was a loss of ₹113 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹4,602 crore at ₹1,328.80 a share.

What is the Zota Health Care PB ratio (price to book value)?

Zota Health Care's price-to-book (PB) ratio is 7.36 at the 30 October 2026 close: a market capitalisation of ₹4,602 crore divided by shareholders' equity (book value) of ₹626 crore on 30 September 2026. That is a book value of ₹180.64 per share against a share price of ₹1,328.80.

What is the Zota Health Care debt to equity ratio?

Zota Health Care's debt-to-equity ratio was 0.05 on 30 September 2026: borrowings of ₹32 crore against total equity of ₹627 crore. A year earlier, on 30 September 2025, it was 0.02.

What is the Zota Health Care market cap?

Zota Health Care's market capitalisation was ₹4,602 crore at the 30 October 2026 close: 3.46 crore shares at ₹1,328.80 each.

Is Zota Health Care debt free?

No. Zota Health Care had borrowings of ₹32 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.05. Its cash and current investments were ₹77.6 crore, so it held net cash of ₹45.5 crore.

What is the Zota Health Care dividend in 2026 and its record date?

In 2026, Zota Health Care has declared one dividend: ₹1 with record date 21 September 2026.

What is the Zota Health Care net worth?

Zota Health Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹626 crore on 30 September 2026, up 98.1% from ₹316 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹4,602 crore at the 30 October 2026 close.

What is the Zota Health Care book value per share?

Zota Health Care's book value per share was ₹180.64 on 30 September 2026: shareholders' equity of ₹626 crore divided by the 3.46 crore shares in issue. The share price at the 30 October 2026 close was ₹1,328.80.

What is the Zota Health Care free cash flow?

In FY26, Zota Health Care generated ₹84.4 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹84.4 crore. In FY25 it was −₹50 crore.

What is the Zota Health Care ROE and ROCE?

In FY26, Zota Health Care's return on equity (ROE) was −16.1% and its return on capital employed (ROCE) was −10.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −36.0% and ROCE −19.8%.

What is the Zota Health Care shareholding pattern?

On 30 September 2026, Zota Health Care's shares were held by promoters 49.38%, foreign portfolio investors (FII/FPI) 6.92%, domestic institutions (DII) 7.30% (including mutual funds at 0.37%) and retail and other non-institutional investors 36.40%. Over the year, FII holding was up 3.43 percentage points from 3.49% and DII holding was up 2.35 percentage points from 4.95%.

What are the Zota Health Care latest quarterly results?

Zota Health Care's latest results are for Q2 FY27 (July–September 2026), filed on 28 October 2026: consolidated net loss ₹25.6 crore, wider than the loss of ₹15.9 crore in Q2 FY26; revenue from operations ₹199 crore, up 54.6% year on year.

What is the Zota Health Care EPS?

Zota Health Care's basic earnings per share (EPS) were −₹22.46 in FY26, against −₹20.68 in FY25.

What is the Zota Health Care promoter holding?

Promoters held 49.38% of Zota Health Care on 30 September 2026, unchanged from the previous quarter and down 6.43 percentage points from 55.81% a year earlier, according to the shareholding pattern filed with NSE.

What is the Zota Health Care revenue and profit in FY26?

In FY26 (April 2025–March 2026), Zota Health Care's consolidated net loss was ₹73.9 crore, wider than the loss of ₹56.4 crore in FY25, on revenue from operations of ₹539 crore (up 83.9%).

When are the Zota Health Care next results?

Zota Health Care has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

How does Zota Health Care compare with its peers?

On FY26 consolidated figures, against Marine Electricals: Zota Health Care's operating margin of −11.9% is the lower of the two (Marine Electricals 9.1%; peer average 9.1%); its return on equity of −16.1% is the lower of the two (Marine Electricals 13.0%; peer average 13.0%); its revenue growth over three years of 56.7% a year is the higher of the two (Marine Electricals 25.6% a year; peer average 25.6% a year).

Zota Health Care vs Marine Electricals: how do they compare?

In FY26, Zota Health Care earned net profit of ₹73.9 crore on revenue of ₹539 crore, against ₹58.4 crore on ₹877 crore for Marine Electricals. Zota Health Care's operating margin was −11.9% (Marine Electricals 9.1%) and its return on equity −16.1% (Marine Electricals 13.0%). At the 30 October 2026 close, Zota Health Care's market capitalisation was ₹4,602 crore against ₹5,593 crore for Marine Electricals.

Where do these Zota Health Care figures come from?

From Zota Health Care's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.